Insula Neuromodulation for Chronic Neuropathic Pain
RecruitingNCT05404581Phase: NAStarted 2022-11-01
Summary
This study will comprehensively investigate the insula as a brain target for neuromodulation to treat chronic neuropathic pain.
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
80 Years
Locations
University of VirginiaCharlottesville, Virginia, United States
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT05404581